(Q53623548)

English

Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

author name string

Kazuki Yamanaka

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Palma Rocchi

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Hideaki Miyake

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Ladan Fazli

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Alan So

5

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Uwe Zangemeister-Wittke

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Martin E Gleave

7

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

publication date

1 June 2006

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

BJU International

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

97

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

1300-1308

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Hormonal therapy: historical perspective to future directions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Mechanisms of the development of androgen independence in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

BCL-2 family: regulators of cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Clusterin: physiologic and pathophysiologic considerations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Clusterin inhibits apoptosis by interacting with activated Bax

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Antisense oligonucleotide-based therapeutics for cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Antisense therapy for cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Enhanced gene silencing by the application of multiple specific small interfering RNAs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Antisense therapy: current status in prostate cancer and other malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Functional analysis of the human MCL-1 gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

The Bcl-2 family of proteins: regulators of cell death and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Glycobiology and cancer: meeting summary and future diections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense BCL-XL and antisense Bcl-2 oligonucleotides plus taxol after castration in the Shionogi tumor model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06147.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.06147.X

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16686729

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53623548&oldid=1365425937"